88 related articles for article (PubMed ID: 7979151)
1. [The creation of diet-dependent cancer models using transgenesis in animals].
Cartier N; Briand P; Kahn A
Ann Gastroenterol Hepatol (Paris); 1994 Sep; 30(4):175-9; discussion 180. PubMed ID: 7979151
[TBL] [Abstract][Full Text] [Related]
2. [Creation of diet-dependent cancer models in transgenic animals].
Cartier N; Briand P; Kahn A
Bull Acad Natl Med; 1994 Jan; 178(1):23-32; discussion 32-4. PubMed ID: 8038992
[TBL] [Abstract][Full Text] [Related]
3. Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter.
Cartier N; Miquerol L; Tulliez M; Lepetit N; Levrat F; Grimber G; Briand P; Kahn A
Oncogene; 1992 Jul; 7(7):1413-22. PubMed ID: 1620553
[TBL] [Abstract][Full Text] [Related]
4. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
5. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
[TBL] [Abstract][Full Text] [Related]
6. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC; Klimstra DS; Varmus HE
Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].
Liu P; Zhao Z; Dominique B
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417
[TBL] [Abstract][Full Text] [Related]
9. Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.
Dupressoir A; Heidmann T
Oncogene; 1997 Jun; 14(24):2951-8. PubMed ID: 9205102
[TBL] [Abstract][Full Text] [Related]
10. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
11. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS
Cancer Res; 1993 Apr; 53(8):1719-23. PubMed ID: 8467484
[TBL] [Abstract][Full Text] [Related]
13. A sucrose-rich diet induces mutations in the rat colon.
Dragsted LO; Daneshvar B; Vogel U; Autrup HN; Wallin H; Risom L; Møller P; Mølck AM; Hansen M; Poulsen HE; Loft S
Cancer Res; 2002 Aug; 62(15):4339-45. PubMed ID: 12154038
[TBL] [Abstract][Full Text] [Related]
14. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
15. Inducible formation of liver tumors in transgenic mice.
Rüther U; Woodroofe C; Fattori E; Ciliberto G
Oncogene; 1993 Jan; 8(1):87-93. PubMed ID: 8423999
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
[TBL] [Abstract][Full Text] [Related]
17. Immortalization of neuro-endocrine cells from adrenal tumors arising in SV40 T-transgenic mice.
Cairns LA; Crotta S; Minuzzo M; Ricciardi-Castagnoli P; Pozzi L; Ottolenghi S
Oncogene; 1997 Jun; 14(25):3093-8. PubMed ID: 9223673
[TBL] [Abstract][Full Text] [Related]
18. Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas.
Strom A; Bonal C; Ashery-Padan R; Hashimoto N; Campos ML; Trumpp A; Noda T; Kido Y; Real FX; Thorel F; Herrera PL
Development; 2007 Aug; 134(15):2719-25. PubMed ID: 17596282
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
[TBL] [Abstract][Full Text] [Related]
20. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas.
Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M
Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
